Gilles Tuffal

586 total citations
14 papers, 451 citations indexed

About

Gilles Tuffal is a scholar working on Molecular Biology, Epidemiology and Analytical Chemistry. According to data from OpenAlex, Gilles Tuffal has authored 14 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Analytical Chemistry. Recurrent topics in Gilles Tuffal's work include Mycobacterium research and diagnosis (4 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Glycosylation and Glycoproteins Research (3 papers). Gilles Tuffal is often cited by papers focused on Mycobacterium research and diagnosis (4 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Glycosylation and Glycoproteins Research (3 papers). Gilles Tuffal collaborates with scholars based in France, United States and Netherlands. Gilles Tuffal's co-authors include Jean‐Ulrich Mullot, Valérie Pichon, Sandrine Macé, Marie‐Claire Hennion, Marlies H.G. Langenberg, Karl Hsu, Michel Rivière, Vincent A. de Weger, Jan H.M. Schellens and Germain Puzo and has published in prestigious journals such as Analytical Chemistry, British Journal of Cancer and Journal of Chromatography A.

In The Last Decade

Gilles Tuffal

14 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gilles Tuffal France 9 140 119 115 104 68 14 451
Teruaki Okuda Japan 14 114 0.8× 21 0.2× 85 0.7× 58 0.6× 34 0.5× 25 463
Sunanda A. Ranadive United States 6 111 0.8× 46 0.4× 83 0.7× 41 0.4× 25 0.4× 7 460
Paul Toren United States 11 206 1.5× 41 0.3× 25 0.2× 193 1.9× 52 0.8× 22 661
P. Farina Italy 11 202 1.4× 53 0.4× 44 0.4× 165 1.6× 47 0.7× 30 453
Ivan Raška Czechia 16 314 2.2× 28 0.2× 27 0.2× 86 0.8× 86 1.3× 36 718
Haruo Iwabuchi Japan 14 260 1.9× 29 0.2× 37 0.3× 167 1.6× 37 0.5× 34 578
Olaf Kuhlmann Switzerland 14 88 0.6× 33 0.3× 32 0.3× 109 1.0× 27 0.4× 27 427
Baomin Xin United States 17 286 2.0× 329 2.8× 65 0.6× 86 0.8× 113 1.7× 26 1.1k
Ian Holmes United States 13 162 1.2× 54 0.5× 27 0.2× 80 0.8× 12 0.2× 34 609
H. Narjes Germany 11 111 0.8× 69 0.6× 27 0.2× 114 1.1× 75 1.1× 17 461

Countries citing papers authored by Gilles Tuffal

Since Specialization
Citations

This map shows the geographic impact of Gilles Tuffal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Tuffal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Tuffal more than expected).

Fields of papers citing papers by Gilles Tuffal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Tuffal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Tuffal. The network helps show where Gilles Tuffal may publish in the future.

Co-authorship network of co-authors of Gilles Tuffal

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Tuffal. A scholar is included among the top collaborators of Gilles Tuffal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Tuffal. Gilles Tuffal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Tiraboschi, Gilles, Gilles Tuffal, David Fabre, et al.. (2023). Population pharmacokinetic modeling and dosing simulation of avalglucosidase alfa for selecting alternative dosing regimen in pediatric patients with late-onset pompe disease. Journal of Pharmacokinetics and Pharmacodynamics. 50(6). 461–474. 4 indexed citations
3.
Weger, Vincent A. de, Maja J.A. de Jonge, Marlies H.G. Langenberg, et al.. (2018). A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours. British Journal of Cancer. 120(3). 286–293. 46 indexed citations
4.
Jonge, Maja J.A. de, Vincent A. de Weger, Mark A. Dickson, et al.. (2017). A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours. European Journal of Cancer. 76. 144–151. 105 indexed citations
5.
Varga, A, Maja J.A. de Jonge, Marlies H.G. Langenberg, et al.. (2015). 303 A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumors. European Journal of Cancer. 51. S55–S55. 3 indexed citations
6.
Lolkema, Martijn P., Mark A. Dickson, Axel Le Cesne, et al.. (2014). 378 A first-in-human (FIH) safety and pharmacological study of SAR405838, a novel HDM2 antagonist, in patients with solid malignancies. European Journal of Cancer. 50. 121–122. 8 indexed citations
7.
Karaźniewicz‐Łada, Marta, Dorota Danielak, Artur Tężyk, et al.. (2012). HPLC–MS/MS method for the simultaneous determination of clopidogrel, its carboxylic acid metabolite and derivatized isomers of thiol metabolite in clinical samples. Journal of Chromatography B. 911. 105–112. 48 indexed citations
8.
Schofield, Joe, Pierre Savi, Nicolas Brémond, et al.. (2011). An improved method for specific and quantitative determination of the clopidogrel active metabolite isomers in human plasma. Thrombosis and Haemostasis. 105(4). 696–705. 81 indexed citations
9.
Mullot, Jean‐Ulrich, et al.. (2008). Selective and automated sample pretreatment by molecularly imprinted polymer for the analysis of the basic drug alfuzosin from plasma. Journal of Chromatography A. 1196-1197. 73–80. 31 indexed citations
10.
Mullot, Jean‐Ulrich, et al.. (2006). Molecularly imprinted polymers for the clean-up of a basic drug from environmental and biological samples. Journal of Chromatography A. 1135(2). 127–134. 65 indexed citations
11.
12.
13.
Tuffal, Gilles, et al.. (1995). Structural Elucidation of Novel Methylglucose‐Containing Polysaccharides from Mycobacterium xenopi. European Journal of Biochemistry. 233(1). 377–383. 14 indexed citations
14.
Tuffal, Gilles, et al.. (1995). Purification and LSIMS Analysis of Methyl Glucose Polysaccharides fromMycobacterium xenopi, a Slow Growing Mycobacterium1. Journal of Carbohydrate Chemistry. 14(4-5). 631–642. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teruaki Okuda Breakdown of academic impact, for papers by Sunanda A. Ranadive Breakdown of academic impact, for papers by Paul Toren Breakdown of academic impact, for papers by P. Farina Breakdown of academic impact, for papers by Ivan Raška Breakdown of academic impact, for papers by Haruo Iwabuchi Breakdown of academic impact, for papers by Olaf Kuhlmann Breakdown of academic impact, for papers by Baomin Xin Breakdown of academic impact, for papers by Ian Holmes Breakdown of academic impact, for papers by H. Narjes
Rankless by CCL
2026